InCurA

Democratizing access to high-quality medical devices in MENA

Business Model
B2B
Last Round
Pre-SeedMar 2024
Rounds
1

About

InCurA is a MedTech company based in Saudi Arabia that develops and commercializes AI-optimized hemostatic medical devices for bleeding control in dental, surgical, and emergency settings. The company addresses the innovation gap in the MENA region by connecting biomedical research to licensed local manufacturing in KSA, with distribution across GCC countries and Egypt. Its lead products include collagen and gelatin sponges (ColiSorB) and starch hemostatic powders (CurASeal). InCurA was selected as a top-10 startup at MedTech World and operates at the intersection of R&D, clinical trials, and manufacturing partnerships.

Summary

InCurA is a Biotech company based in Saudi Arabia. Its most recent funding was a Pre-Seed round in Mar 2024. Investors include Kaust Innovation Fund, Pharos Capital Group and AUC Angels.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-SeedMar 2024

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

InCurA on Indexed.vc
<a href="https://indexed.vc/companies/incura"><img src="https://indexed.vc/api/badge/company/incura" alt="InCurA on Indexed.vc" width="260" height="76" /></a>